A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine.
Ontology highlight
ABSTRACT: Recombinant protein vaccines, with highly pure ingredients and good safety, are gradually replacing some attenuated and inactivated vaccines in clinical practice. However, since their low immunogenicity of the recombinant proteins, adjuvants are often needed to enhance immune response after vaccination. Aluminum adjuvant has been widely used in some vaccines for decades, it can induce strong humoral immunity, but the deficiency of cellular immunity limits its application for some vaccines. Therefore, it is urgently needed to develop novel adjuvant to increase not only humoral but also cellular immune response. To address this, we designed and prepared a new nano adjuvant (PF3) through microfluidization by the combination of saponin (Ginsenoside Rg1) and oil-in-water nano emulsion (NE) in t
SUBMITTER: Shan P
PROVIDER: S-EPMC9127465 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA